Metabolomic in Critical Ill Patients

Terminated

• Conditions: Metabolomic

• Registration Number: NCT01506674
• Lead Sponsor: Università Vita-Salute San Raffaele

Brief Summary

Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-01-09
• Study First Submitted QC: 2012-01-09
• Study First Posted: 2012-01-10
• Study Start: 2015-01-27
• Primary Completion: 2017-10-31
• Study Completion: 2023-04-06
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-16
• Last Update Posted: 2024-01-18

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 94

Inclusion Criteria

• patients with severe left or right ventricular dysfunction undergoing cardiac surgery
• patients undergoing ablation of ventricular tachycardia
• patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
• patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria

• pregnant women
• no written consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metabolomic patterns to identify poor outcome	hospital stay (approximately two weeks)

Trial Locations

Locations (1)

Università Vita-Salute San Raffaele; 🇮🇹 Milano, Mi, Italy